![]() |
FAQ | Contact Us | Blog | Partners | News & Events |

Home Page / Resources / Product Literature ...
NEW RF360 High Resolution System for TOF
From sample prep to data acquisition in one step, no test compound method development or batch building.
RapidFire® Mass Spectrometry System
Label free screening of native analytes, faster ADME data without compromising assay integrity.
RapidFire® Lead Discovery Service
Providing solutions to intractable assays
RapidFire® CYP Inhibition Screening Service
Mass spec based data at the speed of fluorescence
RapidFire® in vitro ADME Screening Service
Increase your laboratory’s efficiency while preserving assay method integrity.
RapidFire® Drug Discovery Solution
Lead compounds for a wide range of targets
Sirtuin Application Notes:
SIRT1 Enzyme & RapidFire® Screening Analysis
A
a pre-validated assay solution that saves time and money
SIRT2 Enzyme & RapidFire® Screening Analysis
A pre-validated assay solution that saves time and money
LPxC Application Note:
LpxC RapidFire® Screening Analysis: Methodology developed at BIOCIUS screens both the gram negative Escherichia coli and gram positive Pseudomonas aeruginosa LpxC-catalyzed reactions.
Application Note:
CYP Inhibition Screening with the RapidFire Platform: Consistent High-throughput Data Across Mass Spectrometry Platforms
Application Note:
Lead Discovery using the RapidFire Platform: Enabling quick go/no-go decisions on lead compounds.
BIOCIUS. Faster Answers.
RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,